Insider Transactions in Q4 2025 at Pieris Pharmaceuticals, Inc. (PIRS)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2025
|
Kathleen Goin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,302
-100.0%
|
$412,992
$96.47 P/Share
|
|
Dec 17
2025
|
Kathleen Goin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,302
+41.65%
|
$34,416
$8.11 P/Share
|
|
Nov 19
2025
|
Kathleen Goin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,302
-67.43%
|
$369,972
$86.12 P/Share
|
|
Nov 19
2025
|
Kathleen Goin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,302
+41.65%
|
$34,416
$8.11 P/Share
|